From: Dietary biomarkers: advances, limitations and future directions
Food/Dietary componenta | Reference | Biomarkerb (Sample size) | Biological sample | Analytic procedurec | Biomarker classd | Validitye,f (p value) | Reproductivityf (p value) | Sensitivityg |
---|---|---|---|---|---|---|---|---|
Carbohydrates | ||||||||
Cane Sugar/HFCS | Cook et al. (2009) | 13C in blood glucose (5 young adults) | Plasma | GC-IRMS | Short term | R2=0.90 (<0.001) | Â | Â |
 | Yeung et al. (2010) | 13C (186 older adults) | Serum (fasting) | CF-SIRMS |  | r=0.87 (0.01) |  |  |
 | Davy et al. (2011) | 13C (60 adults) | Fingerstick | NA-SIMS | Medium term? | r=0.365 (<0.05) | r=0.873 (<0.001) |  |
Sugar | Tasevska et al. (2005) | Sucrose & Fructose (12 male adults; 13 adults) | Urine (24 hr) | Enzymatic | Short term | R2= 0.888 (<0.001) | ICC 0.67i | + |
 | Kuhnle et al. (2008) | Sucrose (7 adults) | Urine (24 hr) | GC-MS | Short term |  |  |  |
 |  |  | Urine (24 hr) | LC-MS | Short term |  |  |  |
Whole-Grain Wheat/Rye | Linko-Parvinen et al. (2007) | Enterolactone (ENL) (15 adults) | Plasma (fasting) | TR-FIA | Short term | Â | Â | Â |
 |  | Total Alkylreoscinol (AR) concentration | Plasma (fasting) | GC-MS | Short term | R2=0.939 (<0.05) |  |  |
 |  | Erythrocyte AR | RBC (fasting) | GC-MS | Medium term? | R2=0.854 (<0.05) |  |  |
 | Aurbertin-Leheudre et al. (2008) | Total AR concentration (56 women) | Plasma (fasting) | GC-MS |  | r=0.406 (0.003) |  |  |
 |  | DHBA | Urine (24 hr) | HPLC |  | r= 0.359 (0.008) |  |  |
 |  | DHPPA | Urine (24 hr) | HPLC |  | r= 0.402 (0.003) |  |  |
 | Landberg et al. (2008, 2009, 2009) | DHBA, DHPPA (16 adults) | Urine (24 hr) | HPLC | Short term |  |  |  |
 |  | Total AR concentration (30 adults; 17 males with prostate cancer) | Plasma (fasting) | GC-MS | Short term | r= 0.58 (<0.001) | ICC 0.90, 0.88i | + |
 | Aderson et al. (2011) | Total AR concentration (51 adults) | Plasma (fasting) | GC-MS | Medium term | r=0.53 (<0.001) | r=0.38 (P<0.001) |  |
Fats | ||||||||
Total Fat | King et al. (2006) | PUFA, MUFA, SFA | RBC (fasting) | 1D-TLC | Long term? | Â | Â | + |
 |  | (66 postmenopausal females) | Plasma (fasting) | 1D-TLC |  |  |  | + |
Fatty Acids | Baylin et al. (2002) | PUFA (503 older Costa Ricans) | Adipsoe tissue (fasting) | GLC | Â | r=0.58 (<0.001) | Â | Â |
 |  | Trans-fatty acids | Adipose tissue (fasting) | GLC |  | r=0.43 (<0.001) |  |  |
 | Poppitt et al. (2005) | SFA, MUFA, PUFA | RBC (fasting) | GC |  |  |  |  |
 |  | (20 male adults) |  |  |  |  |  |  |
 | Fuhrman et al. (2006) | Oleic acid (204 female adults) | RBC (fasting) | GC | Medium term | r=0.45; 0.47* (<0.001) |  |  |
 |  | Total PUFA | RBC (fasting) | GC | Medium term | r=0.17h; 0.39* (<0.001) |  |  |
 |  | Total MUFA | RBC (fasting) | GC | Medium term | r=0.40; 0.48* |  |  |
 |  |  |  |  |  | (<0.001) |  |  |
 |  | Total SFA | RBC (fasting) | GC |  | r=0.14hi; 0.07*hi |  |  |
 | Thiebaut et al. (2009) | SFA, MUFA, PUFA (1,114 female adults) | Serum (fasting) | GC | Long term | r=0.16–0.29 (<0.0001) |  |  |
Essential Fatty Acids (EFA) | Baylin et al. (2005) | Alpha-linolenic acid & Linoleic acid | Adipose tissue | GLC | Long term | r=0.51; 0.52** (<0.05) | Â | Â |
 |  | (200 Costa Rican adults) | Blood (fasting) | GLC | Long term | r=0.38; 0.43** (<0.05) |  |  |
 |  |  | Plasma (fasting) | GLC | Long term | r=0.39; 0.41** (<0.05) |  |  |
 | Fuhrman et al. (2006) | Linoleic acid (204 female adults) | RBC (fasting) | GC | Medium term | r=0.23; 0.39* (<0.05; <0.001) |  |  |
 |  | Alpha-linolenic acid | RBC (fasting) | GC |  | r=0.14hi, 0.07*hi |  |  |
EPA, DHA | Kuriki et al. (2003) | EPA (15 male, 79 female Japanese dietitians) | Plasma (fasting) | GC | Â | r=0.57; 0.60*** (<0.05; <0.001) | Â | Â |
 |  | DHA | Plasma (fasting) | GC |  | r=0.57; 0.30** (<0.05; <0.01) |  |  |
 | Harris et al. (2004) | Omega-3 Index (EPA+DHA) (57 adults) | Plasma (fasting) | GC | Long term | r=0.91(<0.001) |  | + |
 |  |  | Blood (fasting) | GC | Long term | r=0.91 (<0.001) |  | + |
 | O’Brien et al (2009) | 15N-EPA (496 adult Eskimos) | Blood | CF-IRMS |  | r=0.47(<0.001) |  |  |
 |  | 15N-DHA | Blood | CF-IRMS |  | r=0.46 (<0.001) |  |  |
 | Nash et al. (2009) | 15N-EPA (144 adult Eskimos) | Hair | CF-IRMS | Medium term | r=0.83 (0.001) |  |  |
 |  | 15N-DHA | Hair | CF-IRMS | Medium term | r=0.84 (<0.001) |  |  |
Olive Oil | Micro-Casas et al. (2002) | Tyrosol (7 adults) | Urine (24 hr) | GC-MS | Short term | Â | Â | Â |
 |  | Hydroxytyrosol | Urine (24 hr) | GC-MS | Short term |  |  |  |
Proteins | Â | Â | Â | Â | Â | Â | Â | Â |
Protein | Bingham (2003) | Urine Nitrogen (8 adults) | Urine (24 hr) | Kjeldahl | Short term | R2=0.99i | Â | Â |
Animal Protein | Petzke & Lemke (2009) | 13C (14 young adult females) | Hair | GC/C/IRMS | Medium term-Long term? | R2=0.44 (0.005) | Â | Â |
 |  | 15N | Hair | GC/C/IRMS | Medium term- Long term? | R2=0.17h (0.069) |  |  |
 | Cross et al. (2011) | Creatinine (17 male adults) | Urine (24 hr) | Kinetic assay | Short term | Ptrend(<0.0001) |  | +? |
 |  | Taurine | Urine (24 hr) | IEC | Short term? | Ptrend(<0.0001) |  | +? |
 |  | 1-methylhistidine | Urine (24 hr) | IEC | Short term? | Ptrend(<0.0001) |  | + |
 |  | 3-methylhistidine | Urine (24 hr) | IEC | Short term | Ptrend(<0.0001) |  | + |